Changes in Incidence and Epidemiological Characteristics of Pulmonary Tuberculosis in Mainland China, 2005-2016

Jiang, Hui; Li, Mengyang; Zhang, Yingjie; Yin, Jinfeng; Li, Zhiwei; Zhu, Chendi; Li, Qihuan; Luo, Xiangyu; Ji, Tingting; Zhang, Junjie; Yang, Yang; Wang, Xiaonan; Luo, Yanxia; Tao, Lixin; Zhang, Feng; Liu, Xiangtong; Liu, Weimin; Guo, Xiuhua

doi:10.1001/jamanetworkopen.2021.5302

Cited by 46 publications

(50 citation statements)

References 20 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Therefore, prevention and control of hepatitis B in adults, especially young adults, is still a substantial challenge. For tuberculosis, delayed diagnosis is common in low- and middle-income countries [39] , which may increase the incidence of tuberculosis. Besides, tuberculosis patients in Eastern Europe and the Middle East countries are mainly refugees [40] , and there might be underreporting issues, resulting in an underestimation of disease burden.…”

Section: Discussionmentioning

confidence: 99%

Incidence trend and disease burden of seven vaccine-preventable diseases in Shandong province, China, 2013–2017: Findings from a population-based observational study

Yin

Wang

et al. 2022

Vaccine: X

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 99%

Incidence trend and disease burden of seven vaccine-preventable diseases in Shandong province, China, 2013–2017: Findings from a population-based observational study

Yin

Wang

et al. 2022

Vaccine: X

View full text Add to dashboard Cite

“…As suggested in this study, a series of COVID-19 control measures might reduce the community transmission of tuberculosis. However, China has a large base of tuberculosis patients, high drug resistance rate, unsatisfactory therapeutic effect, and low cure rate (21). During the outbreak period, the closure of many medical institutions and emergency clinics, the suspension of admission of tuberculosis patients in some designated tuberculosis hospitals, the decrease in the number of tuberculosis screening patients, and the delay or interruption of treatment of tuberculosis patients may increase the risk of potential tuberculosis infection and the probability of chronic transmission.…”

Section: Discussionmentioning

confidence: 99%

Changes in Incidence of Notifiable Infectious Diseases in China Under the Prevention and Control Measures of COVID-19

Chen

Wang

Huang

et al. 2021

Front. Public Health

View full text Add to dashboard Cite

Aim: The aim of this study was to analyze the changes in incidence of notifiable infectious diseases in China under the prevention and control measures of COVID-19.Methods: Using descriptive epidemiological methods, data were collected from the official website of the Health Commission of the People's Republic of China, and the prevalence characteristics of notifiable infectious diseases in the country in 2020 were analyzed and compared with the historical data in 2019. Monthly reporting data on influenza and tuberculosis from 2015 to 2019 were also collected.Results: Except for COVID-19, the total number of notifiable infectious diseases cases in 2020 was 6,366,176, a decrease of 41.38% year-on-year compared with 2019. Category B and C notifiable infectious diseases decreased by 14.84 and 54.98% year-on-year, respectively (P < 0.01). The top three incidence rates were influenza (87.63 cases/100,000), hepatitis B (81.36 cases/100,000) and other infectious diarrhea (76.33 cases/100,000). Three types of diseases with the largest decline were influenza (−2,280,502 cases), hand-foot-mouth disease (−1,174,588 cases), and other infectious diarrhea diseases (−275,746 cases). Compared with 2019, respiratory infectious diseases were reported to be in the largest decline in 2020, followed by intestinal infectious diseases, blood-borne and sexually transmitted diseases, natural foci, and insect-borne infectious diseases. The monthly reported incidences of influenza and tuberculosis in 2020 were lower than the average of the previous 5 years.Conclusion: In 2020, the incidence of most notifiable infectious diseases in China showed a downward trend, non-pharmaceutical interventions (NPIs)such as the wearing of masks, frequent hand-washing, more ventilation, less gathering, etc, played an positive role in the prevention and control of respiratory and intestinal infectious diseases. The various public health intervention strategies and measures adopted by China to contain COVID-19 can provide a reference for the prevention and control of infectious diseases in other countries.

show abstract

“…The former is diagnosed by bacteriological evidence acquired by sputum smear and culture or a rapid diagnostic system, such as the GeneXpert MTB/RIF. The latter is diagnosed by chest imaging, epidemiological findings, and clinical symptoms along with other relevant testing [ 17 ]. All identifications are based on the National Diagnostic Criteria for Pulmonary Tuberculosis (WS288-2008 and WS288-2017) and Classification of Tuberculosis (WS196-2001 and WS196-2017) in China [ 18 , 19 ].…”

Section: Methodsmentioning

confidence: 99%

Bridging the Gap in End Tuberculosis Targets in the Elderly Population in Eastern China: Observational Study From 2015 to 2020

Liu¹,

Xie²,

Xie³

et al. 2022

JMIR Public Health Surveill

View full text Add to dashboard Cite

Background With a progressive increase in the aging process, the challenges posed by pulmonary tuberculosis (PTB) are also increasing for the elderly population. Objective This study aimed to identify the epidemiological distribution of PTB among the elderly, forecast the achievement of the World Health Organization’s 2025 goal in this specific group, and predict further advancement of PTB in the eastern area of China. Methods All notified active PTB cases aged ≥65 years from Zhejiang Province were screened and analyzed. The general epidemiological characteristics were depicted and presented using the ArcGIS software. Further prediction of PTB was performed using R and SPSS software programs. Results Altogether 41,431 cases aged ≥65 years were identified by the surveillance system from 2015 to 2020. After excluding extrapulmonary TB cases, we identified 39,832 PTB cases, including laboratory-confirmed (23,664, 59.41%) and clinically diagnosed (16,168, 40.59%) PTB. The notified PTB incidence indicated an evident downward trend with a reduction of 30%; however, the incidence of bacteriologically positive cases was steady at approximately 60/100,000. Based on the geographical distribution, Quzhou and Jinhua Cities had a higher PTB incidence among the elderly. The delay in PTB diagnosis was identified, and a significantly prolonged treatment course was observed in the elderly. Moreover, a 50% reduction of PTB incidence by the middle of 2024 was predicted using a linear regression model. It was found that using the exponential smoothing model would be better to predict the PTB trend in the elderly than a seasonal autoregressive integrated moving average model. Conclusions More comprehensive and effective interventions such as active PTB screening combined with physical checkup and succinct health education should be implemented and strengthened in the elderly. A more systematic assessment of the PTB epidemic trend in the elderly population should be considered to incorporate more predictive factors.

show abstract

Changes in Incidence and Epidemiological Characteristics of Pulmonary Tuberculosis in Mainland China, 2005-2016

Cited by 46 publications

References 20 publications

Incidence trend and disease burden of seven vaccine-preventable diseases in Shandong province, China, 2013–2017: Findings from a population-based observational study

Incidence trend and disease burden of seven vaccine-preventable diseases in Shandong province, China, 2013–2017: Findings from a population-based observational study

Changes in Incidence of Notifiable Infectious Diseases in China Under the Prevention and Control Measures of COVID-19

Bridging the Gap in End Tuberculosis Targets in the Elderly Population in Eastern China: Observational Study From 2015 to 2020

Contact Info

Product

Resources

About